Last updated: 2026-09-16 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Repare Therapeutics Inc. (RPTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Repare Therapeutics Inc. (RPTX) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing RPTX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Repare Therapeutics Inc. (RPTX) moved from $2.57 to $2.65, representing a gain of 3.11% ($0.08).
The stock traded between $2.50 and $2.65 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.23 million shares, up versus the previous seven-day period, indicating higher trading activity.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 129 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Repare Therapeutics Inc. (RPTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.